Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 32

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 32
---
 
    Pending 
      
    202180029643.7 
    02-Mar-2041*
  
    Methods For The Treatment And Prevention Of Lung Infections
    By Administration Of Tafenoquine 
    Pending 
    Australia 
    Pending 
      
    2021231743 
    02-Mar-2041*

    Methods For The Treatment And Prevention Of Lung Infections
    Caused By Gram-Positive Bacteria, Fungus, Or Virus By Administration Of Tafenoquine 
    Pending 
    Hong Kong 
    Pending 
     
    62023078645.6 
    02-Mar-2041*
  
    Methods For The Treatment And Prevention Of Lung Infections
    Caused By Gram-Positive Bacteria, Fungus, Or Virus By Administration Of Tafenoquine 
    11,633,391 
    US 
      
    4/25/2023 
    17/189,544 
    05-May-2041^
  
    Methods For The Treatment And Prevention Of Lung Infections
    Caused By Gram-Positive Bacteria, Fungus, Or Virus By Administration Of Tafenoquine 
    Pending 
    US 
    Pending 
      
    18/300,805 
    02-Mar-2041^
  
    Methods For The Treatment And Prevention Of Lung Infections
    Caused By Fungus By Administration Of Tafenoquine 
    Pending 
    US 
    Pending 
      
    17/683,679 
    02-Mar-2041^
  
    Methods For The Treatment And Prevention Of Lung Infections
    Caused By Sars-Cov-2 Virus By Administration Of Tafenoquine 
    Pending 
    US 
    Pending 
      
    17/683,718 
    02-Mar-2041^

14

Title 
    Patent No. 
    Country 
    Status 
    US Patent
    Date 
    Application 
    No. 
    Estimated/
    Anticipated Expiration Date

    Treatment Of Human Coronavirus Infections Using
    Alpha-Glucosidase Glycoprotein Processing Inhibitors 
    11369592 
    US 
      
     6/28/2022 
    17/180,140# 
    19-Feb-2041^
  
    Treatment Of Human Coronavirus Infections Using